Investment Analysts’ price target changes for Wednesday, February 25th:
Apple (NASDAQ:AAPL) had its price target increased by Moffett Nathanson from $241.00 to $270.00. Moffett Nathanson currently has a neutral rating on the stock.
Accenture (NYSE:ACN) had its price target lowered by Citigroup Inc. from $266.00 to $215.00. They currently have a neutral rating on the stock.
Aflac (NYSE:AFL) had its price target increased by Wells Fargo & Company from $109.00 to $118.00. The firm currently has an equal weight rating on the stock.
Akebia Therapeutics (NASDAQ:AKBA) had its target price trimmed by BTIG Research from $5.00 to $4.00. They currently have a buy rating on the stock.
Applied Materials (NASDAQ:AMAT) had its price target increased by Morgan Stanley from $420.00 to $432.00. The firm currently has an overweight rating on the stock.
AMC Entertainment (NYSE:AMC) had its price target lowered by Roth Mkm from $2.00 to $1.50. The firm currently has a neutral rating on the stock.
Advanced Micro Devices (NASDAQ:AMD) had its target price increased by Mizuho from $275.00 to $280.00. The firm currently has an outperform rating on the stock.
Advanced Micro Devices (NASDAQ:AMD) had its price target boosted by The Goldman Sachs Group, Inc. from $210.00 to $240.00. The firm currently has a neutral rating on the stock.
American Homes 4 Rent (NYSE:AMH) had its target price cut by Keefe, Bruyette & Woods from $37.00 to $35.00. The firm currently has an outperform rating on the stock.
American Tower (NYSE:AMT) had its price target trimmed by Morgan Stanley from $225.00 to $220.00. They currently have an overweight rating on the stock.
American Tower (NYSE:AMT) had its price target increased by BMO Capital Markets from $185.00 to $200.00. They currently have a market perform rating on the stock.
American Tower (NYSE:AMT) had its target price reduced by TD Cowen from $235.00 to $225.00.
American Tower (NYSE:AMT) had its target price reduced by Scotiabank from $220.00 to $214.00. Scotiabank currently has a sector outperform rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price trimmed by Wedbush from $20.00 to $18.00. Wedbush currently has a neutral rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price raised by HC Wainwright from $45.00 to $48.00. They currently have a buy rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price trimmed by Royal Bank Of Canada from $22.00 to $21.00. They currently have a sector perform rating on the stock.
Amer Sports (NYSE:AS) had its target price increased by Evercore Inc from $50.00 to $51.00. They currently have an outperform rating on the stock.
Astronics (NASDAQ:ATRO) had its target price increased by Truist Financial Corporation from $75.00 to $107.00. The firm currently has a buy rating on the stock.
AngloGold Ashanti (NYSE:AU) had its price target raised by Scotiabank from $131.00 to $134.00. Scotiabank currently has a sector outperform rating on the stock.
Axon Enterprise (NASDAQ:AXON) had its price target reduced by Barclays PLC from $702.00 to $682.00. Barclays PLC currently has an overweight rating on the stock.
Axon Enterprise (NASDAQ:AXON) had its target price reduced by Morgan Stanley from $713.00 to $675.00. Morgan Stanley currently has an overweight rating on the stock.
Axon Enterprise (NASDAQ:AXON) had its price target lowered by Piper Sandler from $753.00 to $690.00. The firm currently has an overweight rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its target price raised by Morgan Stanley from $96.00 to $98.00. They currently have an overweight rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its target price boosted by Truist Financial Corporation from $86.00 to $95.00. They currently have a buy rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its price target reduced by Oppenheimer Holdings, Inc. from $83.00 to $81.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Boise Cascade (NYSE:BCC) had its target price boosted by Truist Financial Corporation from $92.00 to $103.00. They currently have a buy rating on the stock.
Boise Cascade (NYSE:BCC) had its target price increased by The Goldman Sachs Group, Inc. from $85.00 to $94.00. The firm currently has a neutral rating on the stock.
Beam Therapeutics (NASDAQ:BEAM) had its price target increased by Royal Bank Of Canada from $22.00 to $26.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Beam Therapeutics (NASDAQ:BEAM) had its target price increased by Wedbush from $57.00 to $65.00. They currently have an outperform rating on the stock.
Bausch Health Cos (NYSE:BHC) had its price target trimmed by Barclays PLC from $8.00 to $7.00. They currently have an equal weight rating on the stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target reduced by Guggenheim from $106.00 to $86.00. They currently have a buy rating on the stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target trimmed by HC Wainwright from $60.00 to $55.00. HC Wainwright currently has a neutral rating on the stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by Sanford C. Bernstein from $90.00 to $94.00. Sanford C. Bernstein currently has an outperform rating on the stock.
Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) had its price target increased by Royal Bank Of Canada from $97.00 to $106.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
DMC Global (NASDAQ:BOOM) had its price target lowered by Roth Mkm from $12.00 to $10.00. Roth Mkm currently has a buy rating on the stock.
Bowhead Specialty (NYSE:BOW) had its price target lowered by Royal Bank Of Canada from $33.00 to $30.00. They currently have an outperform rating on the stock.
Caterpillar (NYSE:CAT) had its price target increased by Daiwa Securities Group Inc. from $640.00 to $790.00.
Caterpillar (NYSE:CAT) had its target price raised by Wells Fargo & Company from $756.00 to $870.00. The firm currently has an overweight rating on the stock.
CAVA Group (NYSE:CAVA) had its target price raised by Telsey Advisory Group from $85.00 to $88.00. Telsey Advisory Group currently has an outperform rating on the stock.
CAVA Group (NYSE:CAVA) had its price target increased by TD Cowen from $85.00 to $90.00. They currently have a buy rating on the stock.
CAVA Group (NYSE:CAVA) had its target price boosted by Royal Bank Of Canada from $80.00 to $90.00. The firm currently has an outperform rating on the stock.
CAVA Group (NYSE:CAVA) had its price target boosted by Piper Sandler from $71.00 to $85.00. Piper Sandler currently has an overweight rating on the stock.
CAVA Group (NYSE:CAVA) had its price target raised by Sanford C. Bernstein from $75.00 to $84.00. The firm currently has an outperform rating on the stock.
CAVA Group (NYSE:CAVA) had its target price boosted by Morgan Stanley from $80.00 to $83.00. Morgan Stanley currently has an equal weight rating on the stock.
Chemours (NYSE:CC) had its target price raised by The Goldman Sachs Group, Inc. from $14.00 to $18.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
CareDx (NASDAQ:CDNA) had its target price raised by Wells Fargo & Company from $18.00 to $21.00. They currently have an equal weight rating on the stock.
CECO Environmental (NASDAQ:CECO) had its target price boosted by Roth Mkm from $58.00 to $68.00. Roth Mkm currently has a buy rating on the stock.
CECO Environmental (NASDAQ:CECO) had its target price raised by HC Wainwright from $55.00 to $90.00. The firm currently has a buy rating on the stock.
CECO Environmental (NASDAQ:CECO) had its price target boosted by Needham & Company LLC from $75.00 to $80.00. They currently have a buy rating on the stock.
Grupo Cibest (NYSE:CIB) had its target price increased by The Goldman Sachs Group, Inc. from $69.00 to $76.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Cipher Mining (NASDAQ:CIFR) had its price target lowered by HC Wainwright to $25.00. The firm currently has a buy rating on the stock.
Cipher Mining (NASDAQ:CIFR) had its price target lowered by Needham & Company LLC to $22.00. They currently have a buy rating on the stock.
Clarivate (NYSE:CLVT) had its target price reduced by Royal Bank Of Canada from $5.00 to $3.00. The firm currently has a sector perform rating on the stock.
Clarivate (NYSE:CLVT) had its target price cut by Barclays PLC from $4.00 to $2.40. They currently have an underweight rating on the stock.
Centene (NYSE:CNC) had its target price raised by Truist Financial Corporation from $47.00 to $49.00. Truist Financial Corporation currently has a buy rating on the stock.
Corebridge Financial (NYSE:CRBG) had its target price cut by Wells Fargo & Company from $37.00 to $36.00. Wells Fargo & Company currently has an overweight rating on the stock.
Cardiff Oncology (NASDAQ:CRDF) had its price target trimmed by Piper Sandler from $10.00 to $6.00. The firm currently has an overweight rating on the stock.
CoStar Group (NASDAQ:CSGP) had its price target cut by Royal Bank Of Canada from $75.00 to $57.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
CoStar Group (NASDAQ:CSGP) had its price target reduced by Wells Fargo & Company from $48.00 to $44.00. Wells Fargo & Company currently has an underweight rating on the stock.
CoStar Group (NASDAQ:CSGP) had its target price lowered by Keefe, Bruyette & Woods from $75.00 to $70.00. The firm currently has an outperform rating on the stock.
CoStar Group (NASDAQ:CSGP) had its price target reduced by Needham & Company LLC from $80.00 to $60.00. They currently have a buy rating on the stock.
CoStar Group (NASDAQ:CSGP) had its price target trimmed by Citizens Jmp from $78.00 to $73.00. The firm currently has a market outperform rating on the stock.
CoStar Group (NASDAQ:CSGP) had its price target lowered by The Goldman Sachs Group, Inc. from $84.00 to $73.00. The firm currently has a buy rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its target price increased by Citizens Jmp from $88.00 to $96.00. Citizens Jmp currently has a market outperform rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its target price boosted by Needham & Company LLC from $84.00 to $85.00. They currently have a buy rating on the stock.
Caesars Entertainment (NASDAQ:CZR) had its price target cut by Morgan Stanley from $27.00 to $25.00. The firm currently has an equal weight rating on the stock.
Day One Biopharmaceuticals (NASDAQ:DAWN) had its price target trimmed by Needham & Company LLC from $18.00 to $17.00. Needham & Company LLC currently has a buy rating on the stock.
Day One Biopharmaceuticals (NASDAQ:DAWN) had its price target cut by HC Wainwright from $25.00 to $22.00. The firm currently has a buy rating on the stock.
Day One Biopharmaceuticals (NASDAQ:DAWN) had its price target increased by Wedbush from $29.00 to $30.00. Wedbush currently has an outperform rating on the stock.
Dillard’s (NYSE:DDS) had its price target lowered by Telsey Advisory Group from $700.00 to $650.00. They currently have a market perform rating on the stock.
Dillard’s (NYSE:DDS) had its price target cut by JPMorgan Chase & Co. from $524.00 to $449.00. They currently have an underweight rating on the stock.
Dollar General (NYSE:DG) had its price target boosted by Jefferies Financial Group Inc. from $165.00 to $178.00.
DigitalOcean (NYSE:DOCN) had its price target increased by Bank of America Corporation from $72.00 to $86.00. Bank of America Corporation currently has a buy rating on the stock.
DigitalOcean (NYSE:DOCN) had its price target increased by Citizens Jmp from $60.00 to $83.00. They currently have a market outperform rating on the stock.
DigitalOcean (NYSE:DOCN) had its target price boosted by Cantor Fitzgerald from $68.00 to $83.00. The firm currently has an overweight rating on the stock.
DigitalOcean (NYSE:DOCN) had its target price increased by Oppenheimer Holdings, Inc. from $60.00 to $85.00. The firm currently has an outperform rating on the stock.
DigitalOcean (NYSE:DOCN) had its price target raised by Barclays PLC from $63.00 to $69.00. The firm currently has an overweight rating on the stock.
DigitalOcean (NYSE:DOCN) had its target price raised by The Goldman Sachs Group, Inc. from $50.00 to $78.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Domino’s Pizza (NASDAQ:DPZ) had its target price lowered by Guggenheim from $450.00 to $440.00. The firm currently has a neutral rating on the stock.
Dycom Industries (NYSE:DY) had its target price boosted by Bank of America Corporation from $365.00 to $475.00. The firm currently has a buy rating on the stock.
Eldorado Gold (NYSE:EGO) (TSE:ELD) had its target price trimmed by Scotiabank from $59.00 to $58.00. The firm currently has a sector outperform rating on the stock.
Elanco Animal Health (NYSE:ELAN) had its target price raised by Morgan Stanley from $22.00 to $24.00. The firm currently has an equal weight rating on the stock.
Elanco Animal Health (NYSE:ELAN) had its target price raised by KeyCorp from $27.00 to $29.00. KeyCorp currently has an overweight rating on the stock.
Equitable (NYSE:EQH) had its price target lowered by Wells Fargo & Company from $60.00 to $57.00. The firm currently has an overweight rating on the stock.
Establishment Labs (NASDAQ:ESTA) had its target price raised by Stephens from $85.00 to $90.00. The firm currently has an overweight rating on the stock.
Establishment Labs (NASDAQ:ESTA) had its price target increased by Mizuho from $90.00 to $100.00. They currently have an outperform rating on the stock.
Evolent Health (NYSE:EVH) had its target price cut by Needham & Company LLC from $15.00 to $4.00. The firm currently has a buy rating on the stock.
Evolent Health (NYSE:EVH) had its price target trimmed by Royal Bank Of Canada from $5.00 to $3.00. The firm currently has a sector perform rating on the stock.
Evolent Health (NYSE:EVH) had its target price lowered by BTIG Research from $10.00 to $8.00. BTIG Research currently has a buy rating on the stock.
Expeditors International of Washington (NASDAQ:EXPD) had its price target lowered by Susquehanna from $160.00 to $142.00. They currently have a neutral rating on the stock.
Diamondback Energy (NASDAQ:FANG) had its price target raised by Susquehanna from $182.00 to $199.00. Susquehanna currently has a positive rating on the stock.
Ferguson (NYSE:FERG) had its price target increased by Wells Fargo & Company from $280.00 to $285.00. Wells Fargo & Company currently has an overweight rating on the stock.
Ferguson (NYSE:FERG) had its price target increased by Barclays PLC from $278.00 to $295.00. Barclays PLC currently has an overweight rating on the stock.
Ferguson (NYSE:FERG) had its price target raised by Oppenheimer Holdings, Inc. from $255.00 to $280.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Fidelity National Information Services (NYSE:FIS) had its price target cut by TD Cowen from $89.00 to $78.00. They currently have a buy rating on the stock.
Fidelity National Information Services (NYSE:FIS) had its price target reduced by Wolfe Research from $90.00 to $70.00. They currently have an outperform rating on the stock.
Fidelity National Information Services (NYSE:FIS) had its price target cut by Citigroup Inc. from $70.00 to $53.00. The firm currently has a neutral rating on the stock.
Fidelity National Information Services (NYSE:FIS) had its target price trimmed by Susquehanna from $69.00 to $55.00. The firm currently has a neutral rating on the stock.
Fidelity National Information Services (NYSE:FIS) had its target price trimmed by Keefe, Bruyette & Woods from $85.00 to $72.00. The firm currently has an outperform rating on the stock.
Flywire (NASDAQ:FLYW) had its target price reduced by The Goldman Sachs Group, Inc. from $17.00 to $15.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Flywire (NASDAQ:FLYW) had its price target boosted by Royal Bank Of Canada from $18.00 to $20.00. They currently have an outperform rating on the stock.
Freshpet (NASDAQ:FRPT) had its target price increased by Wells Fargo & Company from $82.00 to $90.00. They currently have an overweight rating on the stock.
First Solar (NASDAQ:FSLR) had its price target cut by Royal Bank Of Canada from $258.00 to $236.00. The firm currently has an outperform rating on the stock.
First Solar (NASDAQ:FSLR) had its target price lowered by Susquehanna from $292.00 to $280.00. Susquehanna currently has a positive rating on the stock.
First Solar (NASDAQ:FSLR) had its target price cut by TD Cowen from $320.00 to $253.00. They currently have a buy rating on the stock.
First Solar (NASDAQ:FSLR) had its target price lowered by Mizuho from $326.00 to $271.00. They currently have an outperform rating on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its target price cut by Barclays PLC from $19.00 to $17.00. They currently have an overweight rating on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its target price lowered by Stephens from $24.00 to $21.00. They currently have an overweight rating on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its target price lowered by Guggenheim from $23.00 to $21.00. Guggenheim currently has a buy rating on the stock.
GoDaddy (NYSE:GDDY) had its price target trimmed by Wells Fargo & Company from $145.00 to $77.00. Wells Fargo & Company currently has an equal weight rating on the stock.
GoDaddy (NYSE:GDDY) had its price target reduced by Cantor Fitzgerald from $130.00 to $90.00. They currently have a neutral rating on the stock.
GoDaddy (NYSE:GDDY) had its target price trimmed by Royal Bank Of Canada from $200.00 to $100.00. The firm currently has an outperform rating on the stock.
Globe Life (NYSE:GL) had its target price boosted by Wells Fargo & Company from $170.00 to $171.00. They currently have an overweight rating on the stock.
Golar LNG (NASDAQ:GLNG) had its price target boosted by BTIG Research from $50.00 to $53.00. The firm currently has a buy rating on the stock.
Globus Medical (NYSE:GMED) had its price target increased by Barclays PLC from $118.00 to $123.00. They currently have an overweight rating on the stock.
Globus Medical (NYSE:GMED) had its target price increased by Needham & Company LLC from $112.00 to $114.00. The firm currently has a buy rating on the stock.
HCA Healthcare (NYSE:HCA) had its target price increased by Mizuho from $540.00 to $585.00. Mizuho currently has an outperform rating on the stock.
Home Depot (NYSE:HD) had its target price boosted by Royal Bank Of Canada from $363.00 to $377.00. They currently have a sector perform rating on the stock.
Home Depot (NYSE:HD) had its target price raised by Sanford C. Bernstein from $381.00 to $390.00. The firm currently has a market perform rating on the stock.
Home Depot (NYSE:HD) had its price target increased by Telsey Advisory Group from $410.00 to $435.00. They currently have an outperform rating on the stock.
Home Depot (NYSE:HD) had its price target boosted by Wells Fargo & Company from $395.00 to $420.00. They currently have an overweight rating on the stock.
Home Depot (NYSE:HD) had its target price raised by Wolfe Research from $413.00 to $414.00. The firm currently has an outperform rating on the stock.
Home Depot (NYSE:HD) had its target price raised by Morgan Stanley from $412.00 to $420.00. Morgan Stanley currently has an overweight rating on the stock.
Home Depot (NYSE:HD) had its target price boosted by BNP Paribas Exane from $355.00 to $391.00.
Home Depot (NYSE:HD) had its target price trimmed by The Goldman Sachs Group, Inc. from $413.00 to $409.00.
Home Depot (NYSE:HD) had its price target increased by Guggenheim from $400.00 to $425.00. They currently have a buy rating on the stock.
Hilton Worldwide (NYSE:HLT) had its target price boosted by Sanford C. Bernstein from $304.00 to $322.00.
HP (NYSE:HPQ) had its price target lowered by Morgan Stanley from $18.00 to $16.00. Morgan Stanley currently has an underweight rating on the stock.
HP (NYSE:HPQ) had its price target lowered by Wells Fargo & Company from $25.00 to $18.00. They currently have an underweight rating on the stock.
HP (NYSE:HPQ) had its price target lowered by The Goldman Sachs Group, Inc. from $21.00 to $16.00. They currently have a sell rating on the stock.
HP (NYSE:HPQ) had its target price cut by Barclays PLC from $18.00 to $16.00. They currently have an underweight rating on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its target price cut by Bank of America Corporation from $32.00 to $28.00. Bank of America Corporation currently has an underperform rating on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its target price reduced by Needham & Company LLC from $46.00 to $44.00. Needham & Company LLC currently has a buy rating on the stock.
Henry Schein (NASDAQ:HSIC) had its price target increased by Wells Fargo & Company from $76.00 to $87.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Henry Schein (NASDAQ:HSIC) had its price target raised by Morgan Stanley from $58.00 to $61.00. They currently have an underweight rating on the stock.
Henry Schein (NASDAQ:HSIC) had its target price raised by Mizuho from $81.00 to $88.00. They currently have a neutral rating on the stock.
Henry Schein (NASDAQ:HSIC) had its price target raised by JPMorgan Chase & Co. from $78.00 to $92.00. The firm currently has an overweight rating on the stock.
Iamgold (NYSE:IAG) (TSE:IMG) had its price target increased by Scotiabank to $25.00. They currently have a sector perform rating on the stock.
International Business Machines (NYSE:IBM) had its price target lowered by Morgan Stanley from $304.00 to $247.00. They currently have an equal weight rating on the stock.
Innovative Industrial Properties (NYSE:IIPR) had its target price raised by Piper Sandler from $44.00 to $45.00. They currently have an underweight rating on the stock.
Invitation Home (NYSE:INVH) had its target price cut by Keefe, Bruyette & Woods from $31.00 to $28.00. The firm currently has a market perform rating on the stock.
Samsara (NYSE:IOT) had its price target cut by BMO Capital Markets from $50.00 to $40.00. They currently have an outperform rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its target price lowered by Chardan Capital from $17.00 to $16.00. The firm currently has a buy rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. Barclays PLC currently has an overweight rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its target price increased by Royal Bank Of Canada from $191.00 to $195.00. The firm currently has an outperform rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target boosted by Morgan Stanley from $225.00 to $226.00. They currently have an overweight rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its target price boosted by Wells Fargo & Company from $235.00 to $250.00. Wells Fargo & Company currently has an overweight rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its target price raised by Bank of America Corporation from $263.00 to $275.00. Bank of America Corporation currently has a buy rating on the stock.
JPMorgan Chase & Co. (NYSE:JPM) had its target price cut by Truist Financial Corporation from $334.00 to $330.00.
Keurig Dr Pepper (NASDAQ:KDP) had its price target boosted by Wells Fargo & Company from $35.00 to $40.00. They currently have an overweight rating on the stock.
KLA (NASDAQ:KLAC) had its price target increased by Morgan Stanley from $1,751.00 to $1,809.00. Morgan Stanley currently has an overweight rating on the stock.
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its target price increased by Wells Fargo & Company from $50.00 to $53.00. The firm currently has an overweight rating on the stock.
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its target price increased by Wedbush from $50.00 to $53.00. The firm currently has an outperform rating on the stock.
Krystal Biotech (NASDAQ:KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. The firm currently has a buy rating on the stock.
Quaker Houghton (NYSE:KWR) had its price target cut by Royal Bank Of Canada from $190.00 to $184.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Lucid Group (NASDAQ:LCID) had its price target lowered by Cantor Fitzgerald from $21.00 to $14.00. Cantor Fitzgerald currently has a neutral rating on the stock.
LivaNova (NASDAQ:LIVN) had its price target raised by Needham & Company LLC from $64.00 to $81.00. Needham & Company LLC currently has a buy rating on the stock.
Lam Research (NASDAQ:LRCX) had its target price increased by Morgan Stanley from $244.00 to $254.00. The firm currently has an equal weight rating on the stock.
MercadoLibre (NASDAQ:MELI) had its target price lowered by Barclays PLC from $2,900.00 to $2,600.00. The firm currently has an overweight rating on the stock.
MercadoLibre (NASDAQ:MELI) had its price target trimmed by Cantor Fitzgerald from $2,750.00 to $2,400.00. The firm currently has an overweight rating on the stock.
MercadoLibre (NASDAQ:MELI) had its price target reduced by Wedbush from $2,600.00 to $2,400.00. Wedbush currently has an outperform rating on the stock.
MercadoLibre (NASDAQ:MELI) had its price target trimmed by BTIG Research from $2,750.00 to $2,650.00. BTIG Research currently has a buy rating on the stock.
MetLife (NYSE:MET) had its price target lowered by Wells Fargo & Company from $97.00 to $93.00. The firm currently has an overweight rating on the stock.
Merit Medical Systems (NASDAQ:MMSI) had its target price cut by Needham & Company LLC from $108.00 to $101.00. The firm currently has a buy rating on the stock.
Marqeta (NASDAQ:MQ) had its price target lowered by Morgan Stanley from $6.00 to $5.00. They currently have an equal weight rating on the stock.
Nabors Industries (NYSE:NBR) had its target price raised by Barclays PLC from $50.00 to $65.00. They currently have an underweight rating on the stock.
Realty Income (NYSE:O) had its target price increased by Stifel Nicolaus from $67.75 to $70.50. They currently have a buy rating on the stock.
Realty Income (NYSE:O) had its price target increased by Royal Bank Of Canada from $61.00 to $70.00. Royal Bank Of Canada currently has an outperform rating on the stock.
ONEOK (NYSE:OKE) had its target price lowered by Wells Fargo & Company from $82.00 to $79.00. The firm currently has an equal weight rating on the stock.
Offerpad Solutions (NYSE:OPAD) had its price target trimmed by Keefe, Bruyette & Woods from $1.75 to $1.00. They currently have a market perform rating on the stock.
Oshkosh (NYSE:OSK) had its price target increased by Wells Fargo & Company from $168.00 to $204.00. The firm currently has an overweight rating on the stock.
Ovintiv (NYSE:OVV) had its price target raised by Barclays PLC from $55.00 to $58.00. They currently have an overweight rating on the stock.
Planet Fitness (NYSE:PLNT) had its price target cut by Royal Bank Of Canada from $130.00 to $120.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Planet Fitness (NYSE:PLNT) had its target price trimmed by JPMorgan Chase & Co. from $120.00 to $105.00. They currently have an overweight rating on the stock.
Primoris Services (NASDAQ:PRIM) had its price target increased by JPMorgan Chase & Co. from $143.00 to $165.00. The firm currently has a neutral rating on the stock.
Primoris Services (NASDAQ:PRIM) had its price target increased by Mizuho from $128.00 to $143.00. The firm currently has a neutral rating on the stock.
Primoris Services (NASDAQ:PRIM) had its target price raised by Guggenheim from $160.00 to $170.00. The firm currently has a buy rating on the stock.
ProPetro (NYSE:PUMP) had its price target boosted by Barclays PLC from $11.00 to $12.00. Barclays PLC currently has an equal weight rating on the stock.
Palvella Therapeutics (NASDAQ:PVLA) had its target price boosted by Mizuho from $205.00 to $250.00. They currently have an outperform rating on the stock.
Palvella Therapeutics (NASDAQ:PVLA) had its target price boosted by BTIG Research from $192.00 to $215.00. The firm currently has a buy rating on the stock.
Qnity Electronics (NYSE:Q) had its price target boosted by Royal Bank Of Canada from $118.00 to $133.00. The firm currently has an outperform rating on the stock.
Resideo Technologies (NYSE:REZI) had its price target raised by Morgan Stanley from $42.00 to $50.00. The firm currently has an overweight rating on the stock.
Reinsurance Group of America (NYSE:RGA) had its target price raised by Wells Fargo & Company from $238.00 to $261.00. The firm currently has an overweight rating on the stock.
Repligen (NASDAQ:RGEN) had its target price cut by Wells Fargo & Company from $190.00 to $180.00. The firm currently has an overweight rating on the stock.
Repligen (NASDAQ:RGEN) had its price target cut by Barclays PLC from $200.00 to $175.00. Barclays PLC currently has an overweight rating on the stock.
Ross Stores (NASDAQ:ROST) had its target price boosted by Telsey Advisory Group from $175.00 to $220.00. The firm currently has a market perform rating on the stock.
Revolve Group (NYSE:RVLV) had its price target boosted by BTIG Research from $30.00 to $35.00. BTIG Research currently has a buy rating on the stock.
Revolve Group (NYSE:RVLV) had its price target boosted by Piper Sandler from $25.00 to $30.00. The firm currently has an overweight rating on the stock.
Revolve Group (NYSE:RVLV) had its target price increased by Morgan Stanley from $27.00 to $29.00. They currently have an equal weight rating on the stock.
Boston Beer (NYSE:SAM) had its price target reduced by Morgan Stanley from $245.00 to $235.00. Morgan Stanley currently has an equal weight rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its price target cut by Royal Bank Of Canada from $10.00 to $9.00. They currently have an outperform rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its target price reduced by Morgan Stanley from $9.50 to $8.50. The firm currently has an equal weight rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its price target reduced by Barclays PLC from $10.00 to $9.00. They currently have an overweight rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its price target reduced by Wells Fargo & Company from $10.00 to $9.00. They currently have an equal weight rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its target price cut by Needham & Company LLC from $14.00 to $12.00. Needham & Company LLC currently has a buy rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its target price lowered by Guggenheim from $12.00 to $11.00. Guggenheim currently has a buy rating on the stock.
Steven Madden (NASDAQ:SHOO) had its price target trimmed by Needham & Company LLC from $50.00 to $41.00. Needham & Company LLC currently has a buy rating on the stock.
Slide Insurance (NASDAQ:SLDE) had its price target increased by Barclays PLC from $25.00 to $29.00. They currently have an overweight rating on the stock.
SPX Technologies (NYSE:SPXC) had its target price boosted by Oppenheimer Holdings, Inc. from $240.00 to $272.00. They currently have an outperform rating on the stock.
SPX Technologies (NYSE:SPXC) had its price target boosted by Wells Fargo & Company from $220.00 to $270.00. The firm currently has an overweight rating on the stock.
Sunoco (NYSE:SUN) had its target price raised by Wells Fargo & Company from $65.00 to $67.00. The firm currently has an overweight rating on the stock.
Tarsus Pharmaceuticals (NASDAQ:TARS) had its price target boosted by Guggenheim from $87.00 to $90.00. Guggenheim currently has a buy rating on the stock.
Tarsus Pharmaceuticals (NASDAQ:TARS) had its price target increased by Oppenheimer Holdings, Inc. from $95.00 to $105.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Tempus AI (NASDAQ:TEM) had its target price reduced by JPMorgan Chase & Co. from $80.00 to $60.00. The firm currently has a neutral rating on the stock.
Tempus AI (NASDAQ:TEM) had its target price cut by Needham & Company LLC from $100.00 to $75.00. They currently have a buy rating on the stock.
Tempus AI (NASDAQ:TEM) had its price target trimmed by BTIG Research from $105.00 to $90.00. They currently have a buy rating on the stock.
The Hanover Insurance Group (NYSE:THG) had its price target raised by Keefe, Bruyette & Woods from $207.00 to $208.00. They currently have an outperform rating on the stock.
TransMedics Group (NASDAQ:TMDX) had its price target boosted by Piper Sandler from $140.00 to $160.00. They currently have an overweight rating on the stock.
TransMedics Group (NASDAQ:TMDX) had its target price boosted by Needham & Company LLC from $166.00 to $174.00. They currently have a buy rating on the stock.
TransMedics Group (NASDAQ:TMDX) had its price target increased by JPMorgan Chase & Co. from $114.00 to $149.00. They currently have a neutral rating on the stock.
TransMedics Group (NASDAQ:TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. The firm currently has an outperform rating on the stock.
Toll Brothers (NYSE:TOL) had its target price raised by Keefe, Bruyette & Woods from $143.00 to $170.00. The firm currently has a market perform rating on the stock.
Trex (NYSE:TREX) had its price target increased by Barclays PLC from $32.00 to $39.00. They currently have an underweight rating on the stock.
Unum Group (NYSE:UNM) had its target price trimmed by Wells Fargo & Company from $104.00 to $102.00. Wells Fargo & Company currently has an overweight rating on the stock.
Veeva Systems (NYSE:VEEV) had its target price lowered by Barclays PLC from $305.00 to $250.00. Barclays PLC currently has an overweight rating on the stock.
Voya Financial (NYSE:VOYA) had its price target trimmed by Wells Fargo & Company from $86.00 to $85.00. The firm currently has an equal weight rating on the stock.
Verra Mobility (NASDAQ:VRRM) had its target price cut by Morgan Stanley from $24.00 to $20.00. Morgan Stanley currently has an equal weight rating on the stock.
Verra Mobility (NASDAQ:VRRM) had its target price reduced by JPMorgan Chase & Co. from $25.00 to $24.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
V2X (NYSE:VVX) had its price target raised by Morgan Stanley from $61.00 to $66.00. They currently have an underweight rating on the stock.
Workday (NASDAQ:WDAY) had its price target reduced by Barclays PLC from $230.00 to $200.00. The firm currently has an overweight rating on the stock.
Workday (NASDAQ:WDAY) had its price target lowered by Sanford C. Bernstein from $298.00 to $214.00. They currently have an outperform rating on the stock.
Workday (NASDAQ:WDAY) had its price target reduced by The Goldman Sachs Group, Inc. from $238.00 to $206.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Workday (NASDAQ:WDAY) had its target price reduced by Oppenheimer Holdings, Inc. from $200.00 to $165.00. They currently have an outperform rating on the stock.
Workday (NASDAQ:WDAY) had its price target reduced by Mizuho from $275.00 to $210.00. The firm currently has an outperform rating on the stock.
Workday (NASDAQ:WDAY) had its target price cut by Wells Fargo & Company from $255.00 to $180.00. Wells Fargo & Company currently has an overweight rating on the stock.
Workday (NASDAQ:WDAY) had its target price cut by Guggenheim from $285.00 to $275.00. The firm currently has a buy rating on the stock.
Workday (NASDAQ:WDAY) had its target price cut by BTIG Research from $230.00 to $175.00. They currently have a buy rating on the stock.
Workday (NASDAQ:WDAY) had its price target cut by Piper Sandler from $200.00 to $135.00. Piper Sandler currently has a neutral rating on the stock.
Workday (NASDAQ:WDAY) had its target price reduced by BMO Capital Markets from $204.00 to $182.00. BMO Capital Markets currently has an outperform rating on the stock.
Workday (NASDAQ:WDAY) had its price target reduced by Rosenblatt Securities from $180.00 to $150.00. They currently have a buy rating on the stock.
Westlake (NYSE:WLK) had its price target boosted by Mizuho from $88.00 to $97.00. They currently have a neutral rating on the stock.
Wynn Resorts (NASDAQ:WYNN) had its target price trimmed by Morgan Stanley from $139.00 to $136.00. The firm currently has an overweight rating on the stock.
Xometry (NASDAQ:XMTR) had its price target reduced by Royal Bank Of Canada from $64.00 to $55.00. They currently have a sector perform rating on the stock.
Xometry (NASDAQ:XMTR) had its target price lowered by Wedbush from $70.00 to $60.00. They currently have an outperform rating on the stock.
Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.
